Free Trial
→ Do NOT Buy SpaceX – Do This Instead (From Stansberry Research) (Ad)tc pixel
NASDAQ:MBOT

Microbot Medical Q3 2026 Earnings Date & Estimates

Microbot Medical logo
$0.95 -0.04 (-4.19%)
Closing price 04:00 PM Eastern
Extended Trading
$0.96 +0.01 (+1.37%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Microbot Medical is estimated to report Q3 2026 earnings on Wednesday, November 11, 2026. The conference call is scheduled for November 13, 2026 at 9:30 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Conference Call Date
Conference Call
9:30 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Microbot Medical in Q3 2026

Microbot Medical is expected to post earnings of -$0.08 per share on revenue of ($0.07) million. In the same quarter a year earlier Microbot Medical reported -$0.07 per share. Microbot Medical last reported on August 11, 2026, posting -$0.08 per share and missing the -$0.0767 consensus estimate. Microbot Medical has beaten the consensus EPS estimate in 3 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.08
Expected Revenue
($0.07) million
Prior-Year EPS
-$0.07

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.08 (Missed by -$0.0033)
Last Quarter Revenue
$0.24 million
EPS Beat Rate
3 of last 8 quarters

Prepare for the Q3 2026 Call

Microbot Medical Q3 2026 Earnings FAQ

Microbot Medical (NASDAQ:MBOT) is estimated to report Q3 2026 earnings on Wednesday, November 11, 2026. This date is estimated from past reporting schedules and may change once the company confirms it.

Microbot Medical's Q3 2026 earnings conference call is scheduled for Friday, November 13, 2026 at 9:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Microbot Medical to post earnings of -$0.08 per share for Q3 2026.

The consensus revenue estimate for Microbot Medical is ($0.07) million for Q3 2026.

Microbot Medical Earnings Headlines

Microbot Medical Signs Three-Year Distribution Deal For LIBERTY In Israel
October 6, 2026  |  rttnews.comhttps://www.rttnews.com/3696891/microbot-medical-signs-three-year-distribution-deal-for-liberty-in-israel.aspx
Microbot Medical Secures Israeli Distribution Deal for LIBERTY
October 6, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/microbot-medical-secures-israeli-distribution-deal-for-liberty?utm_source=marketbeat.com&utm_medium=referral
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel
October 15 at 1:00 AM  |  Altimetry (Ad)
Microbot Medical® and Medtechnica Ltd. Enter into Three-Year Exclusive Distribution Agreement in Israel
October 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/06/3375487/0/en/microbot-medical-and-medtechnica-ltd-enter-into-three-year-exclusive-distribution-agreement-in-israel.html
Microbot Medical Reports High Satisfaction Survey Results and Expands LIBERTY Commercial Footprint to the Western U.S.
September 25, 2026  |  quiverquant.comQ
Microbot Medical® Highlights Growth Strategy
September 25, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/25/3369348/0/en/microbot-medical-highlights-growth-strategy.html
See More Microbot Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Microbot Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Microbot Medical and other key companies, straight to your email.

About Microbot Medical

Microbot Medical (NASDAQ:MBOT) (NASDAQ: MBOT) is a medical device company developing robotic and computer-assisted technologies for minimally invasive endovascular procedures. The company focuses on systems intended to help physicians navigate blood vessels and deliver interventional devices while potentially improving procedural control and reducing radiation exposure to medical personnel.

Microbot Medical’s primary product candidate is the LIBERTY Endovascular Robotic System, a single-use, disposable robotic platform designed to remotely control guidewires and catheters during vascular procedures. The system is being developed to support treatment in challenging anatomy and to reduce the need for physicians to work directly beside radiation-emitting imaging equipment. LIBERTY remains an investigational device and is subject to applicable regulatory review.

The company has roots in Israel and maintains operations in both Israel and the United States. Microbot Medical is led by Harel Gadot, who serves as chairman, president and chief executive officer. Its technologies are being developed for potential use in interventional radiology, vascular medicine and other endovascular applications.

View Microbot Medical Profile
Earnings Tools